Correction: Ran et al. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor. 2023, , 498.
作者信息
Ran Pan, Tan Tao, Zhou Hui, Li Jinjin, Yang Hao, Li Juan, Zhang Jun
机构信息
Department of Gastrointestinal Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Department of Internal Medicine, Chongqing Key Laboratory of Translation Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China.
出版信息
J Pers Med. 2024 Jul 31;14(8):819. doi: 10.3390/jpm14080819.
Abstract
In the original publication [...].
摘要
相似文献
1
Correction: Ran et al. Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor. 2023, , 498.
J Pers Med. 2024 Jul 31;14(8):819. doi: 10.3390/jpm14080819.
2
Correction: Rivera-Picón et al. Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus. 2023, , 269.
J Pers Med. 2023 Jul 31;13(8):1215. doi: 10.3390/jpm13081215.
3
Correction: Saratale et al. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. 2022, , 349.
J Pers Med. 2022 Jun 14;12(6):967. doi: 10.3390/jpm12060967.
4
Correction: Foss et al. The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation. 2022, , 692.
J Pers Med. 2024 Feb 22;14(3):234. doi: 10.3390/jpm14030234.
5
Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. 2022, , 258.
J Pers Med. 2023 Sep 15;13(9):1383. doi: 10.3390/jpm13091383.
6
Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
J Pers Med. 2023 Mar 10;13(3):498. doi: 10.3390/jpm13030498.
7
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. 2022, , 1174.
J Pers Med. 2023 Jan 18;13(2):168. doi: 10.3390/jpm13020168.
8
Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. 2017, , 19.
J Pers Med. 2018 May 7;8(2):18. doi: 10.3390/jpm8020018.
9
Correction: Brauner et al. Dental Management of Maxillofacial Ballistic Trauma. 2022, , 934.
J Pers Med. 2023 Mar 17;13(3):535. doi: 10.3390/jpm13030535.
10
Developed and validated a prognostic nomogram for recurrence-free survival after complete surgical resection of local primary gastrointestinal stromal tumors based on deep learning.
EBioMedicine. 2019 Jan;39:272-279. doi: 10.1016/j.ebiom.2018.12.028. Epub 2018 Dec 23.
本文引用的文献
1
Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor.
J Pers Med. 2023 Mar 10;13(3):498. doi: 10.3390/jpm13030498.
Zotero 插件